Tag: investors

SAN FRANCISCO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Investors in Simulations Plus, Inc. (NASDAQ: SLP) saw the price of their shares decline about 25% on July 15, 2025 after the company reported its Q3 2025 $67.3 million net loss that included a $77.2 million impairment charge and the company’s firing of its independent auditor Grant Thornton, whom it hired on April 15, 2025.

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP notifies investors of the September 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP (“XPLR” or the “Company”) (NYSE:XIFR) securities during the period from September 27, 2023 and January 27, 2025 (“the Class Period”).

CALGARY, Alberta, Aug. 05, 2025 (GLOBE NEWSWIRE) --

Second Quarter Highlights

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

CALGARY, Alberta, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Canoe EIT Income Fund (the “Fund”) (TSX - EIT.UN) announces the August 2025 monthly distribution of $0.10 per unit. Additionally, the Fund announces a quarterly distribution for preferred units. Cumulative Redeemable Series 1 (EIT.PR.A) and Series 2 Preferred (EIT.PR.B) unitholders will receive a distribution of $0.30 per unit. Unitholders of record on August 22, 2025, will receive distributions payable on September 15, 2025.

VERO BEACH, Florida, Aug. 05, 2025 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced that it is commencing an underwritten public offering of 18,500,000 shares of common stock. ARMOUR expects to grant the underwriters a 30-day option to purchase up to 2,775,000 additional shares of its common stock.

MELVILLE, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that it will release its second quarter 2025 financial results after market close on Tuesday, August 12, 2025. Following the announcement, BioRestorative management will host a conference call to review the financial results and provide a business update.